Plasma metabolomic biomarkers of mixed nuts exposure inversely correlate with severity of metabolic syndrome
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
SCOPE: To identify the most discriminant dietary biomarkers of nuts exposure in subjects with metabolic syndrome (MetS), and investigate the potential association between exposure and the severity of the MetS diagnostic traits. METHODS AND RESULTS: We applied the untargeted LC-ESI-qToF-MS-driven metabolomic workflow to explore the changes occurring in the plasma metabolome of MetS subjects following 12-wk intake of mixed nuts (30 g/d; nuts versus control groups). Urolithin A glucuronide was the most discriminative biomarker of nuts exposure, showing the highest predictive capacity (area under the ROC curve = 89.6% [80.8-98.4]) despite the interindividual variation expected for a host-microbial cometabolite. Furthermore, the detection of urolithin A glucuronide in plasma showed significant inverse correlation with basal abdominal adiposity (waist circumference: r = -0.550, p < 0.01; waist-hip ratio: r = -0.409, p < 0.05) and impaired glycemic control (fasting insulin: r = -0.414, p < 0.05; HOMA-IR: r = -0.417, p < 0.05). Significant changes in medium-chain dicarboxylic acids, recognized as alternative energy substrates that are particularly relevant in the case of glycemic control impairment, were also associated with nut consumption. CONCLUSION: Higher levels of utolithin A glucuronide are reported in subjects with less severe MetS traits, especially in females. We believe that this inverse correlation may be related with profile of gut microbial dysbiosis, recently associated to subjects with MetS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368 · cited 1×
“5 performance of the level 1 identified metabolites (Metabolomics Standards Initiative criteria, [40]) in discriminating nut exposure was evaluated by constructing receiver operating characteristic (ROC) curves on the OSC-filtered data set, and estimating the area under the curve [AUC (95% CI)] values (pRoc R package,…”
MethodKrauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2284 · Cited by 1,458
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160
Health Benefits of Nut Consumption
Ros, E. (2010) · Nutrients · doi:10.3390/nu2070652 · Cited by 773
Insights into the role of the microbiome in obesity and type 2 diabetes
Hartstra, A. V., Bouter, K. E. C., Bäckhed, F., & Nieuwdorp, M. (2015) · Diabetes Care · doi:10.2337/dc14-0769 · Cited by 641 · cited 1×
“(dysbiosis) [20], thus the urolithin-producing capacity may be affected by the presence of these cardiometabolic risk factors, thereby impacting on the bioavailability of bioactives from nut polyphenols.”
BackgroundEspín, J. C., Larrosa, M., García-Conesa, M. T., & Tomás-Barberán, F. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/270418 · Cited by 576
The food metabolome: a window over dietary exposure
Scalbert, A., Brennan, L., Manach, C., Andres-Lacueva, C., Dragsted, L. O., Draper, J., Rappaport, S. M., van der Hooft, J. J., & Wishart, D. S. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076133 · Cited by 519
Self-citationTomás-Barberán, F. A., García-Villalba, R., González-Sarrías, A., Selma, M. V., & Espín, J. C. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5024615 · Cited by 419
The blood exposome and its role in discovering causes of disease
Rappaport, S. M., Barupal, D. K., Wishart, D., Vineis, P., & Scalbert, A. (2014) · Environmental Health Perspectives · doi:10.1289/ehp.1308015 · Cited by 393 · cited 1×
“3 potential bioactivity of the dietary components (association between exogenous and endogenous diet-related changes) [23, 26].”
BackgroundMediterranean diet and cardiovascular health: teachings of the PREDIMED study
Ros, E., Martínez-González, M. A., Estruch, R., Salas-Salvadó, J., Fitó, M., Martínez, J. A., & Corella, D. (2014) · Advances in Nutrition · doi:10.3945/an.113.005389 · Cited by 393 · cited 1×
“Both clinical [5] and epidemiological studies [6-8] have associated nut intake with improvements in the diagnostic parameters of MetS, namely abdominal obesity [9], hyperglycemia [3] hypertension [10] and dyslipidemia, and with the reduction of CVD [1, 11-13] through reduction of inflammation and oxidative stress and,…”
BackgroundSelma, M. V., Beltrán, D., García-Villalba, R., Espín, J. C., & Tomás-Barberán, F. A. (2014) · Food Funct. · doi:10.1039/c4fo00092g · Cited by 304 · cited 3×
“Evidence suggests that the enzymatic machinery responsible for the bioconversion of ETs into urolithins may not be ubiquitously shared across the gut microbial community, but little is still known about the specific strains responsible for urolithin production [18, 19, 44].”
BackgroundStorlien, L., Oakes, N. D., & Kelley, D. E. (2004) · Proceedings of the Nutrition Society · doi:10.1079/pns2004349 · Cited by 291
Luo, C., Zhang, Y., Ding, Y., Shan, Z., Chen, S., Yu, M., Hu, F. B., & Liu, L. (2014) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.076109 · Cited by 249
Time course production of urolithins from ellagic acid by human gut microbiota
García-Villalba, R., Beltrán, D., Espín, J. C., Selma, M. V., & Tomás-Barberán, F. A. (2013) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf402498b · Cited by 207
Blanco Mejia, S., Kendall, C. W. C., Viguiliouk, E., Augustin, L. S., Ha, V., Cozma, A. I., Mirrahimi, A., Maroleanu, A., Chiavaroli, L., Leiter, L. A., et al. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-004660 · Cited by 150 · cited 1×
“Both clinical [5] and epidemiological studies [6-8] have associated nut intake with improvements in the diagnostic parameters of MetS, namely abdominal obesity [9], hyperglycemia [3] hypertension [10] and dyslipidemia, and with the reduction of CVD [1, 11-13] through reduction of inflammation and oxidative stress and,…”
BackgroundGarcia-Muñoz, C., & Vaillant, F. (2014) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2011.644643 · Cited by 133 · cited 2×
“The intake of the most abundant polyphenols in walnuts, namely ellagitannins (ETs) [16] has particularly been associated with improvements of metabolic disorders, hence acquiring a growing interest in the food industry as potential functional ingredient [17].”
Background
Cited by
Tomás‐Barberán, F. A., González‐Sarrías, A., García‐Villalba, R., Núñez‐Sánchez, M. A., Selma, M. V., García‐Conesa, M. T., & Espín, J. C. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500901 · Cited by 465
Use of Metabolomics in Improving Assessment of Dietary Intake
Guasch-Ferré, M., Bhupathiraju, S. N., & Hu, F. B. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2017.272344 · Cited by 309
Urolithins: a Comprehensive Update on their Metabolism, Bioactivity, and Associated Gut Microbiota
García‐Villalba, R., Giménez‐Bastida, J. A., Cortés‐Martín, A., Ávila‐Gálvez, M. Á., Tomás‐Barberán, F. A., Selma, M. V., Espín, J. C., & González‐Sarrías, A. (2022) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202101019 · Cited by 302
Guasch-Ferré, M., Merino, J., Sun, Q., Fitó, M., & Salas-Salvadó, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6723931 · Cited by 297
“However, further clinical trials are needed to confirm these associations [59].”
BackgroundMuscogiuri, G., Barrea, L., Di Somma, C., Altieri, B., Vecchiarini, M., Orio, F., Spinosa, T., Colao, A., & Savastano, S. (2019) · Hormones · doi:10.1007/s42000-018-0090-9 · Cited by 48
Metadata
- Authors
- Mora-Cubillos, X., Tulipani, S., Garcia-Aloy, M., Bulló, M., Tinahones, F. J., & Andres-Lacueva, C.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2015-10-21
- Volume
- 59
- Issue
- 12
- Pages
- 2480-2490
- ISSN
- 1613-4125 (ISSN-L)
- OpenAlex
- W1789946263
- Cited by
- 53
- References
- 16
- FWCI
- 5.03
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.